Joann C Blessing-Moore, MD
Allergy & Immunology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Blessing-Moore’s office at (650) 688-8480 to ask if they take your plan before you enroll.
California Medical Board record
Licence G26617 · Current
Licensed to practise in California · since 1974 · expires 2028-09-30 · State University of N.Y. Upstate Medical Ctr, College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$6,227 in 2019
Medicaid paid $6,227 for 182 billed services this clinician did in 2019, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| ANTIGEN THERAPY SERVICES | 37 | $2,608 |
| Return visit (30+ min) | 31 | $1,720 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 33 | $529 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 14 | $495 |
| Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic | 12 | $413 |
| Total vital capacity | 41 | $400 |
| IMMUNOTHERAPY ONE INJECTION | 14 | $61 |
| 2019 | 182 | 7 | 21 | $6,227 |
| 2018 | 1,203 | 6 | 32 | $38,433 |
See the largest Medicaid services in earlier years
2018
| ANTIGEN THERAPY SERVICES | 355 | $17,517 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 265 | $10,127 |
| Long return visit (40+ min) | 58 | $4,802 |
| Return visit (30+ min) | 57 | $3,664 |
| IMMUNOTHERAPY ONE INJECTION | 364 | $1,311 |
| Total vital capacity | 104 | $1,011 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 14 Part D prescriptions in 2021. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2021 | 14 | None | 0% (0) | None | $2,749 |
| 2020 | 27 | 13 | 0% (0) | 63% | $16,047 |
| 2019 | 503 | 101 | 0% (0) | 53% | $184,927 |
| 2018 | 990 | 144 | 0% (0) | 50% | $300,521 |
| 2017 | 1,005 | 137 | 0% (0) | 51% | $381,069 |
| 2016 | 1,238 | 147 | 0% (0) | 54% | $369,505 |
| 2015 | 1,185 | 141 | None | 58% | $373,526 |
| 2014 | 1,032 | 127 | 0% (0) | 59% | $364,525 |
| 2013 | 994 | 114 | None | 59% | $238,479 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2019: 11 drugs
| Xolair | 21 | $61,968 | $2,951 |
| Symbicort | 49 | $28,077 | $573 |
| Spiriva Respimat | 33 | $19,702 | $597 |
| Breo Ellipta | 18 | $6,747 | $375 |
| Flovent Hfa | 21 | $6,362 | $303 |
| Azelastine | 71 | $4,841 | $68 |
| Dymista | 18 | $3,492 | $194 |
| Pazeo | 12 | $3,090 | $257 |
| Qvar Redihaler | 12 | $2,616 | $218 |
| Montelukast | 62 | $813 | $13 |
| Fluticasone Propionate | 55 | $768 | $14 |
2018: 21 drugs
| Xolair | 25 | $76,688 | $3,068 |
| Symbicort | 83 | $39,599 | $477 |
| Spiriva Respimat | 59 | $34,556 | $586 |
| Advair Diskus | 16 | $13,204 | $825 |
| Azelastine | 140 | $9,748 | $70 |
| Dymista | 33 | $8,038 | $244 |
| Epinephrine | 26 | $6,733 | $259 |
| Pazeo | 28 | $6,154 | $220 |
| Flovent Hfa | 16 | $5,999 | $375 |
| Qvar Redihaler | 24 | $4,979 | $207 |
| Breo Ellipta | 14 | $4,970 | $355 |
| Dexilant | 11 | $3,002 | $273 |
| Montelukast | 139 | $2,377 | $17 |
| Budesonide | 11 | $2,168 | $197 |
| Fluticasone Propionate | 106 | $1,233 | $12 |
| Proair Hfa | 13 | $817 | $63 |
| Ranitidine | 29 | $736 | $25 |
| Proair Respiclick | 12 | $712 | $59 |
| Ventolin Hfa | 11 | $619 | $56 |
| Levocetirizine Dihydrochloride | 22 | $506 | $23 |
| Prednisone | 11 | $71 | $6 |
2017: 21 drugs
| Xolair | None | 16 | $41,467 | $2,592 |
| Gammagard S-D | Immune globulin | 13 | $35,531 | $2,733 |
| Symbicort | None | 78 | $34,853 | $447 |
| Spiriva Respimat | None | 62 | $33,160 | $535 |
| Advair Diskus | None | 29 | $17,864 | $616 |
| Epipen 2-Pak | None | 20 | $13,523 | $676 |
| Spiriva | None | 21 | $11,808 | $562 |
| Qvar | None | 43 | $8,467 | $197 |
| Azelastine | None | 113 | $7,034 | $62 |
| Pazeo | None | 31 | $6,092 | $197 |
| Dulera | None | 19 | $5,497 | $289 |
| Alvesco | None | 18 | $4,837 | $269 |
| Flovent Hfa | None | 14 | $4,267 | $305 |
| Epinephrine | None | 12 | $3,292 | $274 |
| Montelukast | None | 178 | $2,920 | $16 |
| Fluticasone Propionate | None | 94 | $1,117 | $12 |
| Proair Hfa | None | 13 | $912 | $70 |
| Levocetirizine Dihydrochloride | None | 20 | $510 | $26 |
| Ranitidine | None | 16 | $129 | $8 |
| Azithromycin | None | 15 | $73 | $5 |
| Prednisone | None | 11 | $58 | $5 |
2016: 25 drugs
| Xolair | None | 14 | $43,597 | $3,114 |
| Symbicort | None | 115 | $41,467 | $361 |
| Spiriva Respimat | None | 82 | $32,945 | $402 |
| Gammagard S-D | Immune globulin | 12 | $30,302 | $2,525 |
| Spiriva | None | 55 | $22,335 | $406 |
| Advair Diskus | None | 38 | $20,882 | $550 |
| Qvar | None | 57 | $10,813 | $190 |
| Epipen 2-Pak | None | 18 | $10,245 | $569 |
| Azelastine | None | 119 | $8,109 | $68 |
| Alvesco | None | 16 | $5,480 | $342 |
| Dymista | None | 16 | $4,992 | $312 |
| Pataday | None | 22 | $4,718 | $214 |
| Dulera | None | 16 | $4,386 | $274 |
| Pazeo | None | 24 | $4,334 | $181 |
| Flovent Hfa | None | 15 | $3,758 | $251 |
| Nasonex | None | 15 | $3,584 | $239 |
| Montelukast | None | 254 | $3,504 | $14 |
| Zetonna | None | 14 | $3,196 | $228 |
| Levocetirizine Dihydrochloride | None | 38 | $1,141 | $30 |
| Fluticasone Propionate | None | 91 | $1,049 | $12 |
| Proair Hfa | None | 15 | $812 | $54 |
| Proair Respiclick | None | 14 | $769 | $55 |
| Ranitidine | None | 22 | $301 | $14 |
| Azithromycin | None | 17 | $141 | $8 |
| Prednisone | None | 14 | $88 | $6 |
2015: 22 drugs
| Xolair | None | 27 | $71,812 | $2,660 |
| Spiriva | None | 133 | $56,466 | $425 |
| Symbicort | None | 108 | $38,442 | $356 |
| Gammagard S-D | Immune globulin | 13 | $31,664 | $2,436 |
| Advair Diskus | None | 28 | $16,538 | $591 |
| Epipen 2-Pak | None | 29 | $13,058 | $450 |
| Spiriva Respimat | None | 26 | $10,931 | $420 |
| Qvar | None | 42 | $8,100 | $193 |
| Azelastine | None | 99 | $7,768 | $78 |
| Nasonex | None | 36 | $7,574 | $210 |
| Zetonna | None | 28 | $6,949 | $248 |
| Alvesco | None | 24 | $6,935 | $289 |
| Dulera | None | 24 | $6,210 | $259 |
| Montelukast | None | 199 | $3,644 | $18 |
| Proair Hfa | None | 23 | $1,222 | $53 |
| Fluticasone Propionate | None | 80 | $1,138 | $14 |
| Levocetirizine Dihydrochloride | None | 36 | $824 | $23 |
| Xopenex Hfa | None | 13 | $784 | $60 |
| Ipratropium | None | 11 | $323 | $29 |
| Ranitidine | None | 19 | $230 | $12 |
| Azithromycin | None | 16 | $197 | $12 |
| Prednisone | None | 14 | $95 | $7 |
2014: 23 drugs
| Spiriva | None | 156 | $56,895 | $365 |
| Gammagard Liquid | Immune globulin | 14 | $53,481 | $3,820 |
| Xolair | None | 11 | $31,613 | $2,874 |
| Symbicort | None | 81 | $30,822 | $381 |
| Gammagard S-D | Immune globulin | 12 | $26,298 | $2,192 |
| Advair Diskus | None | 26 | $13,889 | $534 |
| Alvesco | None | 30 | $11,044 | $368 |
| Epipen 2-Pak | None | 26 | $9,563 | $368 |
| Montelukast | None | 157 | $6,886 | $44 |
| Dulera | None | 23 | $5,446 | $237 |
| Azelastine | None | 64 | $5,442 | $85 |
| Zetonna | None | 25 | $5,124 | $205 |
| Asmanex | None | 19 | $4,000 | $211 |
| Nasonex | None | 21 | $3,982 | $190 |
| Astepro | None | 22 | $3,010 | $137 |
| Qvar | None | 20 | $2,819 | $141 |
| Patanase | None | 11 | $2,794 | $254 |
| Fluticasone Propionate | None | 89 | $1,797 | $20 |
| Levocetirizine Dihydrochloride | None | 35 | $792 | $23 |
| Proair Hfa | None | 11 | $680 | $62 |
| Pantoprazole | None | 16 | $204 | $13 |
| Azithromycin | None | 16 | $134 | $8 |
| Ranitidine | None | 19 | $127 | $7 |
2013: 23 drugs
| Spiriva | None | 116 | $39,139 | $337 |
| Symbicort | None | 94 | $28,343 | $302 |
| Gammagard S-D | Immune globulin | 13 | $26,858 | $2,066 |
| Advair Diskus | None | 34 | $15,124 | $445 |
| Montelukast | None | 188 | $10,696 | $57 |
| Nasonex | None | 34 | $6,172 | $182 |
| Astepro | None | 39 | $5,779 | $148 |
| Asmanex | None | 28 | $4,733 | $169 |
| Dulera | None | 20 | $4,370 | $218 |
| Alvesco | None | 13 | $3,978 | $306 |
| Epipen 2-Pak | None | 15 | $3,812 | $254 |
| Singulair | None | 15 | $3,480 | $232 |
| Patanase | None | 18 | $2,977 | $165 |
| Azelastine | None | 29 | $2,682 | $92 |
| Fluticasone Propionate | None | 80 | $2,396 | $30 |
| Zetonna | None | 12 | $2,375 | $198 |
| Triamcinolone Acetonide | None | 12 | $1,929 | $161 |
| Pataday | None | 12 | $1,731 | $144 |
| Qvar | None | 11 | $1,503 | $137 |
| Proair Hfa | None | 22 | $1,376 | $63 |
| Nasacort Aq | None | 11 | $1,279 | $116 |
| Levocetirizine Dihydrochloride | None | 28 | $656 | $23 |
| Prednisone | None | 16 | $64 | $4 |
Money from drug and device companies
$4,538 in 2021
| 2021 | 3 | 6 | $4,200 | $4,538 |
| 2020 | 4 | 4 | $2,685 | $2,952 |
| 2019 | 14 | 59 | $26,150 | $30,302 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| LEO Pharma | None | $4,200 | 2 payments
|
| ALK-Abello | None | $224 | 3 payments
|
| Grifols Shared Services North America | Xembify | $114 | 1 payment
|
See all 6 published payments
| LEO Pharma | Consulting · 2021-12-23 | None | $2,400 |
| Grifols Shared Services North America | Meals · 2021-06-22 | Xembify | $114 |
| ALK-Abello | Meals · 2021-05-19 | None | $75 |
| ALK-Abello | Meals · 2021-05-05 | None | $75 |
| ALK-Abello | Meals · 2021-02-23 | None | $74 |
| LEO Pharma | Consulting · 2021-01-13 | None | $1,800 |
See earlier years (2020, 2019)
2020: $2,952
| AstraZeneca Pharmaceuticals LP | Fasenra | $2,685 | 1 payment
|
| Optinose US | Xhance | $126 | 1 payment
|
| ALK-Abello | Odactra | $78 | 1 payment
|
| Grifols Shared Services North America | Xembify | $63 | 1 payment
|
2019: $30,302
| GlaxoSmithKline | Nucala | $23,853 | 26 payments
|
| Genentech USA | Xolair | $2,855 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $2,674 | 8 payments
|
| OptiNose US | Xhance | $246 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | None | $200 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $103 | 2 payments
|
| Circassia Pharmaceuticals | Niox Vero | $97 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $57 | 3 payments
|
| Pharming Healthcare | Ruconest | $49 | 1 payment
|
| Grifols Shared Services North America | Gamunex-C | $47 | 2 payments
|
| Novartis Pharmaceuticals | Xolair | $46 | 2 payments
|
| Sunovion Pharmaceuticals | Lonhala Magnair | $45 | 3 payments
|
| CSL Behring | Haegarda | $17 | 1 payment
|
| Pfizer | Eucrisa | $14 | 1 payment
|
Professional record
- NPI
- 1992812358
- Licence
- CA G-26617California G26617: Current · expires 2028-09-30
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207K00000X (207K00000X); Federal specialty code 2080P0214X (2080P0214X)
- Mailing address
- 5 Quail Meadow Dr, Woodside, CA, 94062
- NPI first listed
- 2006-08-23
- NPI last updated
- 2015-01-15
This is when the NPI record was last certified, not a medical board exam.